semaglutide chronic kidney disease Ozempic Approved for Diabetic FDA approves Ozempic to reduce

We follow guidelines from the FDA and Endocrine Society, which recommend that GLP-1 agonists be used alongside healthy eating, increased physical activity, and behavioral changes for the best results

While list prices for GLP-1 medications can still be high, cash-pay programs for Wegovy tablets are notably lower than typical injectable costs: Wegovy pill cash-pay pricing through Novo Nordisks program is advertised at $149/month for the 1.5 mg and 4 mg doses (with the 4 mg offer price available until April 15, 2026), and $299/month for higher doses

Later, in June 2021 , the FDA approved a higher-dose formulation named Wegovy , explicitly t argeted at chronic weight management in patients without diabetes

Tolerability matters